HI TECH PHARMACAL CO INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 8 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-11-10: Reporting owner SELTZER REUBEN; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-11-10: Reporting owner SELTZER DAVID S; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-10-24: Reporting owner SELTZER REUBEN; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-10-10: Reporting owner GOLDWYN MARTIN M; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-11-10 | SELTZER REUBEN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −56,250 0 owned after | $3.84 exercise price | 2011-11-14 | |
| 2011-11-10 | SELTZER DAVID S Director, Officer (CEO, President, Sec'y, Treas.), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −112,500 0 owned after | $3.84 exercise price | 2011-11-14 | |
| 2011-10-24 | SELTZER REUBEN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,250 0 owned after | $4.29 exercise price | 2011-11-14 | |
| 2011-10-10 | GOLDWYN MARTIN M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,595 0 owned after | $4.29 exercise price | 2011-10-11 | |
| 2011-10-06 | HIRSHAUT YASHAR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,250 0 owned after | $4.29 exercise price | 2011-10-11 | |
| 2011-06-06 holding as of filing | SELTZER REUBEN Director, Officer (Vice Chairman-Business Dev't) | 5 | Stock Option (Right to Buy) Derivative · Direct | Holding | 305,000 owned after | no price filed | 2011-06-06 | |
| 2011-06-06 holding as of filing | SELTZER DAVID S Director, Officer (CEO, President, Sec'y, Treas.), 10% Owner | 5 | Stock Option (Right to Buy) Derivative · Direct | Holding | 675,000 owned after | no price filed | 2011-06-06 | |
| 2011-04-26 | Egbaria Kamel Officer (Chief Scientific Officer, EVP) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $27.17 exercise price | 2011-04-29 |